Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $146.7 million.

  • Centessa Pharmaceuticals' Total Non-Current Liabilities rose 3269.86% to $146.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.7 million, marking a year-over-year increase of 3269.86%. This contributed to the annual value of $175.2 million for FY2024, which is 4134.05% up from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Total Non-Current Liabilities stood at $146.7 million, which was up 3269.86% from $147.2 million recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Total Non-Current Liabilities peaked at $175.2 million during Q4 2024, and registered a low of $101.0 million during Q2 2022.
  • Moreover, its 4-year median value for Total Non-Current Liabilities was $112.4 million (2024), whereas its average is $124.0 million.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Total Non-Current Liabilities skyrocketed by 1464.33% in 2023, and later skyrocketed by 4134.05% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $108.1 million in 2022, then grew by 14.64% to $124.0 million in 2023, then surged by 41.34% to $175.2 million in 2024, then dropped by 16.28% to $146.7 million in 2025.
  • Its Total Non-Current Liabilities was $146.7 million in Q3 2025, compared to $147.2 million in Q2 2025 and $141.6 million in Q1 2025.